Future research should focus on combining NSE with other biomarkers (e.g., GFAP, S100B, or inflammatory markers) to improve stroke diagnosis and prognosis, as well as establishing standardized NSE cutoff values for clinical applications. Here, GFAP is linked to stroke disorder.